Your browser doesn't support javascript.
loading
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
Berkhout, Lea C; l'Ami, Merel J; Ruwaard, Jill; Hart, Margreet H; Heer, Pleuni Ooijevaar-de; Bloem, Karien; Nurmohamed, Michael T; van Vollenhoven, Ronald F; Boers, Maarten; Alvarez, Daniel F; Smith, Catherine H; Wolbink, Gerrit J; Rispens, Theo.
Afiliación
  • Berkhout LC; Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
  • l'Ami MJ; Amsterdam Rheumatology and immunology Center, Reade, 1056 AB Amsterdam, Netherlands.
  • Ruwaard J; Amsterdam Rheumatology and immunology Center, Reade, 1056 AB Amsterdam, Netherlands.
  • Hart MH; Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
  • Heer PO; Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
  • Bloem K; Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
  • Nurmohamed MT; Amsterdam Rheumatology and immunology Center, Reade, 1056 AB Amsterdam, Netherlands.
  • van Vollenhoven RF; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
  • Boers M; Amsterdam Rheumatology and immunology Center, Reade, 1056 AB Amsterdam, Netherlands.
  • Alvarez DF; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
  • Smith CH; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Academic Medical Center, 1105 AZ Amsterdam, Netherlands.
  • Wolbink GJ; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
  • Rispens T; Department of Epidemiology and Biostatistics, VU University Medical Center, 1081 HV Amsterdam, Netherlands.
Sci Transl Med ; 11(477)2019 01 30.
Article en En | MEDLINE | ID: mdl-30700574

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioensayo / Factor de Necrosis Tumoral alfa / Tolerancia a Medicamentos / Adalimumab Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bioensayo / Factor de Necrosis Tumoral alfa / Tolerancia a Medicamentos / Adalimumab Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos